All News

Results from a poster at ASHP 2019.

Pharmacists provide clinical training and operational skillsets.

Health systems urged to adopt antibiotic stewardship programs by March 2020. 

Biosimilar to Remicade

Patients with type 2 diabetes should keep taking their medication.

Kroger recently launched an initiative that enables hospitals and health care networks to leverage Kroger resources to provide broader access and value-based health care.

UnitedHealthcare and Walgreens are partnering to open in-store centers.

Allergan’s positive phase 3 trial results indicate a potential use for the CGRP receptor agonist.

Pharmacists can help advocate for availability and coverage.

One in 5 older adults said that they’ve taken leftover antibiotics from a previous prescription without checking in with a health care professional.

Monoclonal antibody originally approved in 2016.

Louisiana, along with other southern and southwestern US states, topped the Walgreens Flu Index report for highest incidences of flu for November.

Conveniently for pharmacists and their patients, both the flu shot and Shingrix (RZV) can be administered during the same clinical visit.

Side-by-side comparisons may persuade patients to receive the vaccine.

A new study shows increases in the misuse of non-opioid medications among US adults coinciding with decreases in opioid prescribing.

Pharmacist-led initiatives, such as medication therapy management, for chronic diseases can significantly improve patient outcomes.

Liquid glass? Isn’t glass solid?

Recent approval under new international Project Orbis.

The role pharmacists have in helping cancer patients.

Non-Hodgkin’s lymphoma rates are increasing, so how can pharmacists help?

What the law says about pharmacists’ role in the opioid crisis-and how to protect yourself.

Buying a pharmacy? Here's what you need to know about depreciation and amortization.

Ultra-rare, potentially life-threatening genetic disease.

Hemoglobin S Polymerization inhibitor oral treatment.

Tips to help COPD patients decrease their flare-up risks.

The range of inhaled therapies has expanded dramatically in recent years.

The FDA issued warning letters to several companies marketing their CBD products in ways that violate the Federal Food, Drug, and Cosmetic Act.

Evidence-based framework is an urgent need, study says.